about
Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing HemodialysisInflammation, neoangiogenesis and fibrosis in peritoneal dialysis.Inflammation and poor response to treatment with erythropoietin in chronic kidney disease.Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.Prognosis biomarkers evaluation in chronic lymphocytic leukemia.ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.Apo B/Apo A-I ratio in central and peripheral arterial diseases.Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.Obesity with no metabolic syndrome and adipose tissue expansion based solely on risk factors and inflammatory marker of coronary heart disease in premenopausal women.Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.Homocysteine and methylenetetrahydrofolate reductase in subjects undergoing coronary angiographyHigh-sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood pressureApolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescentsPolymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patientsLack of association between potential prothrombotic genetic risk factors and arterial and venous thrombosisABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial diseasePaclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity
P50
Q35972437-FB5C7466-0737-4CA6-A0EB-ECDC2B2F3BC9Q38087161-381DC792-17AD-46D9-A949-9A263BC14405Q38543962-7215C8AC-ED91-4466-8233-C6D057F6C813Q38672763-53F1ED94-BB73-46D5-A0B0-806517D4E307Q38968949-D4428987-B6DF-4A77-9B16-57BED5A256ADQ46386815-FA874CEA-B177-4952-BA39-2B38CB392426Q46834667-A8ED9CC8-788C-436F-9257-B4D512437C5EQ46880784-50280676-18D7-467F-9EE6-2C58989522E4Q47206255-92A56270-9813-4B49-B940-F1AF52330128Q64987709-99A0085C-7BC1-4B4B-BC5A-79F59076D64AQ80035316-34AC92A7-FD24-42F2-AC36-77AF12EC7B7AQ81436733-4A99A268-68BA-4845-9B54-6B0930BD9B98Q82742192-7A51EEDA-32EE-4998-ACE9-EBDDD2FDB820Q84592853-A8DD59C3-CC32-4638-941A-389A7F6290B8Q86083418-F48E5E12-8DB5-4122-B12B-995663187119Q87140911-1BF6B883-A8D6-4F5C-96BB-0ED0B06413DFQ93143140-1DFC91FF-D9C8-4E98-872F-7589EDC11447
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Adriano de Paula Sabino
@en
Adriano de Paula Sabino
@nl
type
label
Adriano de Paula Sabino
@en
Adriano de Paula Sabino
@nl
prefLabel
Adriano de Paula Sabino
@en
Adriano de Paula Sabino
@nl
P108
P108
P31
P496
0000-0001-8562-8689